Logo image of TLT.AS

LONDON TUNNELS PLC/THE (TLT.AS) Stock Fundamental Analysis

AMS:TLT - Euronext Amsterdam - GB00BS28ZN53 - Common Stock - Currency: GBP

2.08  -0.02 (-0.95%)

Fundamental Rating

2

TLT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 56 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of TLT is average, but there are quite some concerns on its profitability. TLT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TLT had negative earnings in the past year.
TLT had a negative operating cash flow in the past year.
TLT.AS Yearly Net Income VS EBIT VS OCF VS FCFTLT.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -2M -4M -6M

1.2 Ratios

TLT's Return On Assets of -28.11% is on the low side compared to the rest of the industry. TLT is outperformed by 80.36% of its industry peers.
Looking at the Return On Equity, with a value of -47.36%, TLT is doing worse than 67.86% of the companies in the same industry.
Industry RankSector Rank
ROA -28.11%
ROE -47.36%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TLT.AS Yearly ROA, ROE, ROICTLT.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 200 400 600

1.3 Margins

TLT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TLT.AS Yearly Profit, Operating, Gross MarginsTLT.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

TLT has more shares outstanding than it did 1 year ago.
TLT has a better debt/assets ratio than last year.
TLT.AS Yearly Shares OutstandingTLT.AS Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M 40M 50M
TLT.AS Yearly Total Debt VS Total AssetsTLT.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 11.47 indicates that TLT is not in any danger for bankruptcy at the moment.
TLT has a Altman-Z score of 11.47. This is amongst the best in the industry. TLT outperforms 100.00% of its industry peers.
TLT has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
TLT has a Debt to Equity ratio of 0.05. This is amongst the best in the industry. TLT outperforms 89.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 11.47
ROIC/WACCN/A
WACCN/A
TLT.AS Yearly LT Debt VS Equity VS FCFTLT.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

A Current Ratio of 2.52 indicates that TLT has no problem at all paying its short term obligations.
The Current ratio of TLT (2.52) is better than 96.43% of its industry peers.
TLT has a Quick Ratio of 2.52. This indicates that TLT is financially healthy and has no problem in meeting its short term obligations.
TLT has a better Quick ratio (2.52) than 96.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 2.52
TLT.AS Yearly Current Assets VS Current LiabilitesTLT.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

TLT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -99.34%.
EPS 1Y (TTM)-99.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-113.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -37.56% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-87.58%
EPS Next 2Y-46.15%
EPS Next 3Y-37.56%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TLT.AS Yearly EPS VS EstimatesTLT.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TLT. In the last year negative earnings were reported.
Also next year TLT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLT.AS Price Earnings VS Forward Price EarningsTLT.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TLT.AS Per share dataTLT.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

TLT's earnings are expected to decrease with -37.56% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.15%
EPS Next 3Y-37.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LONDON TUNNELS PLC/THE

AMS:TLT (6/18/2025, 7:00:00 PM)

2.08

-0.02 (-0.95%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.83%
Inst Owner ChangeN/A
Ins Owners71.07%
Ins Owner ChangeN/A
Market Cap146.14M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 14.47
P/tB 65.44
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.26
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0
BVpS0.14
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.11%
ROE -47.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.52
Quick Ratio 2.52
Altman-Z 11.47
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-113.42%
EPS Next Y-87.58%
EPS Next 2Y-46.15%
EPS Next 3Y-37.56%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-91.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-282.01%
EBIT Next 3Y-60.92%
EBIT Next 5YN/A
FCF growth 1Y-2385.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1340.45%
OCF growth 3YN/A
OCF growth 5YN/A